Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 27.69%76.3B | 17.24%59.75B | -9.85%50.97B | 9.08%56.54B | 58.97%51.83B | 24.39%32.6B | -11.40%26.21B | 18.91%29.58B | 37.67%24.88B | 14.67%18.07B |
| Net profit before non-cash adjustment | 7.09%64.71B | 6.68%60.43B | 14.92%56.64B | 12.87%49.29B | 67.22%43.67B | 16.05%26.11B | -20.83%22.5B | 15.26%28.42B | 36.65%24.66B | 23.02%18.04B |
| Total adjustment of non-cash items | 9.19%5.42B | 120.10%4.96B | -35.17%2.25B | -7.11%3.48B | 56.87%3.74B | -63.08%2.39B | 38.20%6.46B | 26.24%4.68B | 140.05%3.7B | -17.38%1.54B |
| -Depreciation and amortization | 23.39%4.74B | 53.11%3.84B | 5.42%2.51B | -1.85%2.38B | -2.53%2.43B | 23.77%2.49B | 54.57%2.01B | -22.00%1.3B | 10.32%1.67B | 26.40%1.51B |
| -Reversal of impairment losses recognized in profit and loss | ---- | --0 | -66.67%27M | --81M | --0 | ---- | 30.53%2.28B | 17.94%1.75B | --1.48B | ---- |
| -Assets reserve and write-off | ---- | --0 | -88.00%3M | -24.24%25M | -83.82%33M | --204M | ---- | ---- | ---- | ---- |
| -Disposal profit | 426.47%222M | -143.59%-68M | -57.14%156M | -35.69%364M | -66.47%566M | 74.92%1.69B | -48.81%965M | 524.17%1.89B | 556.52%302M | 11,545.57%46M |
| -Net exchange gains and losses | 101.72%1M | -26.09%-58M | -84.00%-46M | 56.14%-25M | -319.23%-57M | 1,400.00%26M | -102.41%-2M | 194.32%83M | 47.93%-88M | -8,656.48%-169M |
| -Remuneration paid in stock | 10.77%288M | 128.07%260M | 32.56%114M | 82.98%86M | 143.12%47M | -199.09%-109M | --110M | ---- | ---- | ---- |
| -Other non-cash items | -83.33%164M | 292.94%984M | -190.27%-510M | -22.39%565M | 138.08%728M | -274.61%-1.91B | 420.18%1.1B | -200.88%-342M | 120.13%339M | -23.69%154M |
| Changes in working capital | 209.57%6.17B | 28.93%-5.63B | -309.90%-7.93B | -14.63%3.78B | 7.75%4.42B | 249.16%4.11B | 21.64%-2.75B | -0.86%-3.51B | -129.83%-3.48B | -95.21%-1.52B |
| -Change in receivables | -22.75%-3.66B | 75.78%-2.99B | -667.50%-12.33B | 277.60%2.17B | 70.48%-1.22B | -105.00%-4.14B | 54.82%-2.02B | 55.61%-4.47B | -437.10%-10.08B | -85.41%-1.88B |
| -Change in inventory | 197.67%1.17B | -20.08%-1.2B | -365.58%-1B | -465.79%-215M | -100.93%-38M | 193.54%4.08B | -262.24%-4.37B | -428.51%-1.21B | 67.29%-228M | -260.90%-697M |
| -Change in prepaid assets | 66.74%-159M | -148.19%-478M | 286.12%992M | -759.68%-533M | 76.15%-62M | 82.74%-260M | -201.20%-1.51B | -7,042.86%-500M | 83.33%-7M | -838.76%-42M |
| -Change in payables | 343.22%3.88B | -272.70%-1.59B | 5,529.41%923M | -100.76%-17M | 120.61%2.24B | -30.88%1.01B | 706.04%1.47B | -92.97%182M | 2,351.30%2.59B | -122.82%-115M |
| -Change in accrued expense | 338.33%286M | -287.50%-120M | 276.47%64M | -93.15%17M | -21.52%248M | 85.88%316M | 529.63%170M | 170.00%27M | -82.14%10M | 81.22%56M |
| -Provision for loans, leases and other losses | 845.78%2.48B | -125.94%-332M | 190.25%1.28B | -39.17%441M | 78.13%725M | -52.95%407M | 167.80%865M | -45.71%323M | 2,804.55%595M | -108.79%-22M |
| -Changes in other current liabilities | 102.41%2.18B | -49.67%1.08B | 12.09%2.14B | -24.65%1.91B | -5.65%2.54B | 1.90%2.69B | 23.62%2.64B | -41.29%2.13B | 207.79%3.64B | 435.83%1.18B |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -65.38%-129M | 0.00%-78M | -5.41%-78M | -12.12%-74M | 30.53%-66M | -18.75%-95M | -788.89%-80M | -125.00%-9M | 33.33%-4M | -6M |
| Interest received (cash flow from operating activities) | 1,000.00%66M | -14.29%6M | -30.00%7M | 100.00%10M | 400.00%5M | 1M | 0 | 0 | 0 | 22.55%8M |
| Tax refund paid | 5.65%-16.13B | -20.10%-17.09B | 14.19%-14.23B | -137.40%-16.59B | 9.59%-6.99B | 31.78%-7.73B | -16.82%-11.33B | -47.31%-9.7B | -8.81%-6.58B | -14.61%-6.05B |
| Other operating cash inflow (outflow) | 5M | 0 | 0.00%5M | -16.67%5M | 0.00%6M | 100.00%6M | 0.00%3M | 200.00%3M | -50.00%1M | 2M |
| Operating cash flow | 41.15%60.11B | 16.14%42.59B | -8.08%36.67B | -10.93%39.9B | 80.68%44.79B | 67.41%24.79B | -25.53%14.81B | 8.68%19.88B | 52.11%18.29B | 14.67%12.03B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 40.32%-4.77B | 10.76%-7.99B | -632.90%-8.96B | 62.09%-1.22B | 34.99%-3.22B | -64.23%-4.96B | 33.10%-3.02B | -408.22%-4.51B | -6.60%-888M | -165.37%-833M |
| Net intangibles purchase and sale | -8.78%-1.49B | -336.42%-1.37B | -184.55%-313M | 14.06%-110M | 34.02%-128M | 67.83%-194M | -1,182.98%-603M | 78.54%-47M | -882.14%-219M | 170.90%28M |
| Net business purchase and sale | 32.10%107M | 723.08%81M | 55.17%-13M | 95.61%-29M | -769.74%-661M | 54.76%-76M | 94.45%-168M | -711.52%-3.03B | --495M | ---- |
| Net investment product transactions | -204.30%-97M | 122.25%93M | -15.47%-418M | -142.95%-362M | -96.05%-149M | 93.37%-76M | ---1.15B | ---- | -23.57%-1.88B | ---1.52B |
| Advance cash and loans provided to other parties | 99.13%-1M | -11,400.00%-115M | 50.00%-1M | 0.00%-2M | 50.00%-2M | 98.62%-4M | -34.26%-290M | -7,100.00%-216M | 85.71%-3M | -383.87%-21M |
| Repayment of advance payments to other parties and cash income from loans | -98.15%1M | -68.97%54M | 3,380.00%174M | 25.00%5M | 300.00%4M | -50.00%1M | -33.33%2M | -76.92%3M | -95.99%13M | 5,959.47%324M |
| Net changes in other investments | 93.85%-39M | 40.25%-634M | -342.79%-1.06B | 189.37%437M | 28.09%-489M | 24.53%-680M | -115.04%-901M | -70.33%-419M | -59.74%-246M | -3.24%-154M |
| Investing cash flow | 36.38%-6.29B | 6.70%-9.88B | -725.25%-10.59B | 72.40%-1.28B | 22.37%-4.65B | 2.25%-5.99B | 25.48%-6.13B | -201.61%-8.22B | -25.29%-2.73B | -333.66%-2.18B |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | -136.61%-93M | -11.50%254M | 114.12%287M | ---2.03B | --0 | 45,933.33%22B | -433.33%-48M | -12.50%-9M | ---8M |
| Net common stock issuance | --0 | ---10B | --0 | ---32B | --0 | ---- | ---24.41B | ---- | --0 | -1,722,656.12%-19B |
| Cash dividends paid | -18.81%-32.07B | -50.07%-26.99B | -23.78%-17.99B | -44.26%-14.53B | -50.10%-10.07B | 29.85%-6.71B | -9.66%-9.57B | -75.02%-8.72B | -18.33%-4.98B | -35.51%-4.21B |
| Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---443M | ---- | ---- |
| Net other fund-raising expenses | 77.78%-12M | -800.00%-54M | -100.05%-6M | 95,250.00%11.42B | 80.00%-12M | 25.93%-60M | -8,000.00%-81M | 50.00%-1M | ---2M | ---- |
| Financing cash flow | 13.62%-32.08B | -109.37%-37.14B | 49.06%-17.74B | -187.39%-34.82B | -78.95%-12.12B | 43.85%-6.77B | -30.86%-12.06B | -84.48%-9.22B | 78.49%-5B | -646.82%-23.22B |
| Net cash flow | ||||||||||
| Beginning cash position | -5.93%69.75B | 13.16%74.15B | 6.28%65.52B | 83.47%61.65B | 55.85%33.6B | -12.25%21.56B | 10.93%24.57B | 92.70%22.15B | -53.49%11.5B | 39.53%24.71B |
| Current changes in cash | 591.15%21.75B | -153.06%-4.43B | 120.24%8.35B | -86.48%3.79B | 132.94%28.03B | 456.26%12.03B | -237.95%-3.38B | -76.85%2.45B | 179.09%10.57B | -294.42%-13.37B |
| Effect of exchange rate changes | -128.13%-9M | -74.60%32M | 51.81%126M | 315.00%83M | 300.00%20M | -155.56%-10M | 164.29%18M | -134.15%-28M | 182.00%82M | -191.46%-100M |
| Cash adjustments other than cash changes | 0.00%-1M | -100.65%-1M | --154M | ---- | -95.24%1M | -93.97%21M | --348M | ---- | ---- | 1,520.06%252M |
| End cash Position | 31.17%91.49B | -5.93%69.75B | 13.16%74.15B | 6.28%65.52B | 83.47%61.65B | 55.85%33.6B | -12.25%21.56B | 10.93%24.57B | 92.70%22.15B | -53.49%11.5B |
| Free cash flow | 62.01%53.83B | 21.26%33.23B | -28.94%27.4B | -6.95%38.56B | 111.21%41.44B | 75.59%19.62B | -27.06%11.17B | -10.87%15.32B | 58.35%17.19B | 7.10%10.85B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |